AllianceBernstein’s Rigel Pharmaceuticals RIGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
– Sell
-50,000
Closed -$1.15M – 3133
2018
Q4
$1.15M Buy
+50,000
New +$1.41M ﹤0.01% 2130

Other funds holding RIGL

AllianceBernstein's RIGL Position: Q3 2026 in Review

AllianceBernstein held its Rigel Pharmaceuticals (RIGL) position steady in Q3 2026 at 32,033 shares worth $1.54M. The position accounts for ﹤0.01% of the portfolio, ranked #2210.

AllianceBernstein first reported a position in RIGL in Q2 2013 and has held it in 54 quarters since. The position peaked at $4.31M in Q3 2018. 170 funds tracked by Wall St. Rank hold RIGL as of Q3 2026.

  • AllianceBernstein held 32,033 shares of Rigel Pharmaceuticals worth $1.54M as of Q3 2026.
  • AllianceBernstein left its Rigel Pharmaceuticals share count unchanged in Q3 2026.
  • Rigel Pharmaceuticals made up ﹤0.01% of AllianceBernstein's portfolio in Q3 2026, its #2210 holding.
  • AllianceBernstein first reported a position in Rigel Pharmaceuticals in Q2 2013 and has held it in 54 quarters since.
  • AllianceBernstein's Rigel Pharmaceuticals position peaked at $4.31M in Q3 2018.
  • 170 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q3 2026.

Based on AllianceBernstein's 13F filing for Q3 2026, filed 16 Nov 2026.